---
aliases: >-
  /news/digital-health-interests-of-pharma-giants-boehringer-ingelheim-takeda-astrazeneca-amgen-and-roche
archetype: curated-content
author:
  - Radhika Narayanan
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - >-
    Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda,
    Astrazeneca, Amgen And Roche
categories:
  - 'Symplur: #digitalhealth'
categorySlug:
  - 'symplur: #digitalhealth'
categoryUrl:
  - topic/symplur-digitalhealth
categoryLabel:
  - '#digitalhealth'
contentCategories: netspective-medigy-news-curated-content
institution: null
offering: null
layOut: single
date: '2021-11-05'
description: >-
  Pharmaceutical giants have the potential to shape the digital health
  landscape. In this series we investigated how big pharma prepares for the next
  level in medicine.This third article, which will con
favIconImage: null
featuredImage:
  alt: >-
    Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda,
    Astrazeneca, Amgen And Roche
  format: JPEG
  href: 8f13b2dc-ce05-5ea4-adb5-e5e495018db6-featuredImage.jpeg
  size:
    - 1080
    - 1920
  valid: true
  workPackage: 9681
  wpAttachment:
    fileName: Curated_Featured_Image.png
    link: /api/v3/attachments/18750/content
featuredPdf: null
htmlMetaData:
  author: null
  description: >-
    Pharmaceutical giants have the potential to shape the digital health
    landscape. In this series we investigated how big pharma prepares for the
    next level in medicine.
  generator: null
  viewport: 'width=device-width,initial-scale=1'
  articlemodified_time: '2021-11-04T23:47:49'
  articlepublished_time: '2021-11-04T09:00:00'
  msvalidate.01: null
  ogdescription: >-
    Pharmaceutical giants have the potential to shape the digital health
    landscape. In this series we investigated how big pharma prepares for the
    next level in medicine.
  ogimage: >-
    https://cdn.medicalfuturist.com/wp-content/uploads/2021/11/tmf_article_301-01.png
  ogsite_name: The Medical Futurist
  ogtitle: >-
    Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda,
    Astrazeneca, Amgen And Roche - The Medical Futurist
  ogtype: article
  ogupdated_time: '2021-11-04T23:47:49'
  ogurl: 'https://medicalfuturist.com/big-pharma-part-3/'
  yandex-verification: null
  robots: noodp
  fbapp_id: '1796753533873796'
  oglocale: en_US
  fbadmins: '100000702732950'
  articlepublisher: 'https://www.facebook.com/medicalfuturist'
  google-site-verification: zbobS_w-zKE2TUJArPSIkWdHdx77XjEfnBwC_EZhELY
  keywords: null
id: 9681
identifier: News
lastMod: '2021-11-05T18:26:32.407601Z'
link:
  brand: medicalfuturist.com
  href: 'https://medicalfuturist.com/big-pharma-part-3/'
  original: 'https://medicalfuturist.com/big-pharma-part-3'
href: 'https://medicalfuturist.com/big-pharma-part-3/'
original: 'https://medicalfuturist.com/big-pharma-part-3'
mastHead: NEWS
mdName: 8f13b2dc-ce05-5ea4-adb5-e5e495018db6.md
openGraphMetaData:
  ogdescription: >-
    Pharmaceutical giants have the potential to shape the digital health
    landscape. In this series we investigated how big pharma prepares for the
    next level in medicine.
  ogtitle: >-
    Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda,
    Astrazeneca, Amgen And Roche - The Medical Futurist
  ogurl: 'https://medicalfuturist.com/big-pharma-part-3/'
  ogimage: >-
    https://cdn.medicalfuturist.com/wp-content/uploads/2021/11/tmf_article_301-01.png
  ogsite_name: The Medical Futurist
  ogtype: article
  ogupdated_time: '2021-11-04T23:47:49'
  ogimageheight: null
openProjectCustomFields:
  cleanUrl: 'https://medicalfuturist.com/big-pharma-part-3/'
  medigyTopics:
    - 'Symplur: #digitalhealth'
  sourceUrl: 'https://medicalfuturist.com/big-pharma-part-3'
openProjectWorkPackageType: Curated Content
searchCategory: News
slug: >-
  medicalfuturist-digital-health-interests-of-pharma-giants-boehringer-ingelheim-takeda-astrazeneca-amgen-and-roche
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: >-
  Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda,
  Astrazeneca, Amgen And Roche
via: ' '
insights_description: null
insights_name: null
viaLink: null
relatedOfferings:
  - label: Plexihealth Telehealth Solution
    permalink: /offering/plexihealth-telehealth-solution
    categories:
      - 'Symplur: #digitalhealth'
      - 'KLAS: Practice Management'
      - 'Symplur: #telehealth'
    offeringId: 8958
  - label: Healcard for Doctors
    permalink: /offering/healcard-for-doctors
    categories:
      - 'Symplur: EHR (Electronic Health Record)'
      - 'Symplur: Healthcare Innovation'
      - 'KLAS: Practice Management'
      - 'Symplur: #digitalhealth'
    offeringId: 8845
  - label: Updox Telehealth Videochat
    permalink: /offering/updox-telehealth-videochat
    categories:
      - 'Symplur: #telehealth'
      - 'Symplur: #digitalhealth'
    offeringId: 8701
  - label: Contactless Patient Intake
    permalink: /offering/contactless-patient-intake
    categories:
      - 'KLAS: Patient Intake Management'
      - 'Symplur: #digitalhealth'
      - 'Symplur: #VirtualHealth'
      - 'Symplur: CoronaVirus'
    offeringId: 8688
  - label: pMD® Charge Capture™ and MIPS Registry
    permalink: /offering/pmd-r-charge-capture-and-mips-registry
    categories:
      - 'KLAS: Charge Capture'
      - 'Symplur: #digitalhealth'
      - 'Healthcare IT News: Clinical Registry Tools'
    offeringId: 8684
twitterMetaData:
  twittercard: null
  twitterdescription: >-
    Pharmaceutical giants have the potential to shape the digital health
    landscape. In this series we investigated how big pharma prepares for the
    next level in medicine.
  twittertitle: >-
    Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda,
    Astrazeneca, Amgen And Roche - The Medical Futurist
  twitterimage: >-
    https://cdn.medicalfuturist.com/wp-content/uploads/2021/11/tmf_article_301-01.png
  twitterurl: null
---
<p>Pharmaceutical giants have the potential to shape the digital health landscape. In this series we investigated how big pharma prepares for the next level in medicine.<br><br>This third article, which will conclude the series, will peek into the digital health trends that pharma giants Boehringer Ingelheim, Takeda, AstraZeneca, Amgen and Roche have taken an interest in.</p><p><br>BI has also made moves to improve the patient side of the digital health equation.
Takeda: pushing for digital health innovation
Through TakedaSpark, Takeda aims to boost digital health innovation through new projects and partnerships.</p>